Oscar Health OSCR
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Oscar Health (OSCR) Business Model and Operations Summary
Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.
Key Insights
Oscar Health (OSCR) Core Market Data and Business Metrics
Latest Closing Price
$12.97Market Cap
$3.23 BillionPrice-Earnings Ratio
129.70Total Outstanding Shares
215.05 Million SharesTotal Employees
2,400Dividend
No dividendIPO Date
March 3, 2021SIC Description
Hospital & Medical Service PlansPrimary Exchange
New York Stock ExchangeHeadquarters
75 Varick Street, New York, NY, 10013
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities, Continuing | $68.39 Million |
| Net Cash Flow | $-340.85 Million |
| Net Cash Flow From Operating Activities | $978.19 Million |
| Net Cash Flow From Investing Activities | $-1.39 Billion |
| Net Cash Flow, Continuing | $-340.85 Million |
| Net Cash Flow From Financing Activities | $68.39 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Income/Loss Attributable To Noncontrolling Interest | $689,000 |
| Operating Income/Loss | $57.27 Million |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Operating Expenses | $9.12 Billion |
| Other Operating Expenses | $7.36 Billion |
| Diluted Average Shares | $265.85 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss | $-3.14 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $689,000 |
| Comprehensive Income/Loss Attributable To Parent | $22.30 Million |
| Comprehensive Income/Loss | $22.98 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Liabilities And Equity | $4.84 Billion |
| Equity Attributable To Parent | $1.01 Billion |
| Equity Attributable To Noncontrolling Interest | $2.84 Million |
| Noncurrent Liabilities | $360.84 Million |
| Current Assets | $2.85 Billion |
| Liabilities | $3.82 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||